Capital Market Strategies’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,372
Closed -$214K 157
2024
Q3
$214K Sell
8,372
-629
-7% -$16K 0.13% 137
2024
Q2
$211K Sell
9,001
-243
-3% -$6.13K 0.13% 139
2024
Q1
$266K Sell
9,244
-405
-4% -$12.2K 0.2% 113
2023
Q4
$317K Sell
9,649
-135
-1% -$3.67K 0.28% 93
2023
Q3
$259K Sell
9,784
-510
-5% -$16.7K 0.26% 103
2023
Q2
$351K Sell
10,294
-515
-5% -$16.2K 0.32% 80
2023
Q1
$325K Buy
10,809
+350
+3% +$10.8K 0.58% 33
2022
Q4
$295K Sell
10,459
-441
-4% -$14K 0.32% 87
2022
Q3
$358K Sell
10,900
-348
-3% -$12.8K 0.4% 68
2022
Q2
$354K Sell
11,248
-396
-3% -$13.8K 0.37% 74
2022
Q1
$535K Buy
11,644
+999
+9% +$47.6K 0.46% 54
2021
Q4
$652K Buy
+10,645
New +$736K 0.54% 45

Other funds holding ARKG